Divi's Laboratories Limited

NSE:DIVISLAB.NS

Location

Market Cap

USD 20.53 B

Share Price

USD 77.32

Avg Daily Volume

518,751

Change (1 day)

0.60%

Change (1 year)

42.97%

Change (YTD)

8.53%

Divi's Laboratories Limited Revenue for the year ending March 31, 2024: USD 940.54 M

Divi's Laboratories Limited Revenue is USD 940.54 M for the year ending March 31, 2024, a -0.24% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Divi's Laboratories Limited Revenue for the year ending March 31, 2023 was USD 942.80 M, a -18.64% change year over year.
  • Divi's Laboratories Limited Revenue for the year ending March 31, 2022 was USD 1.16 B, a 23.72% change year over year.
  • Divi's Laboratories Limited Revenue for the year ending March 31, 2021 was USD 936.64 M, a 33.40% change year over year.
  • Divi's Laboratories Limited Revenue for the year ending March 31, 2020 was USD 702.14 M, a 1.04% change year over year.
Key data
Date Revenue Revenue Gross Profit Operating Income
Market news
Loading...
NSE: DIVISLAB.NS

Divi's Laboratories Limited

CEO Dr. Kiran Satchandra Divi B. Pharm., M.Pharm
IPO Date March 12, 2003
Location India
Headquarters Divi Towers
Employees 9,741
Sector 🏥 Health Care
Industries
Description

Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.

Similar companies

600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd

USD 27.70

-0.78%

BMRN

BioMarin Pharmaceutical Inc.

USD 54.08

-1.67%

4151.T

Kyowa Kirin Co., Ltd.

USD 17.15

1.10%

ABBOTINDIA.NS

Abbott India Limited

USD 362.33

0.75%

002422.SZ

Sichuan Kelun Pharmaceutical Co., Ltd.

USD 4.82

1.55%

1SXP.F

SCHOTT Pharma AG & Co. KGaA

USD 32.93

4.52%

000423.SZ

Dong-E-E-Jiao Co.,Ltd.

USD 7.24

-0.89%

688336.SS

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

USD 7.67

2.12%

1513.HK

Livzon Pharmaceutical Group Inc.

USD 3.71

1.26%

600518.SS

Kangmei Pharmaceutical Co., Ltd.

USD 0.26

-0.24%

0867.HK

China Medical System Holdings Limited

USD 1.53

3.48%

002773.SZ

Chengdu Kanghong Pharmaceutical Group Co., Ltd

USD 3.88

-0.02%

GLAND.NS

Gland Pharma Limited

USD 20.61

2.03%

000623.SZ

Jilin Aodong Pharmaceutical Group Co., Ltd.

USD 2.27

0.26%

600062.SS

China Resources Double-Crane Pharmaceutical Co.,Ltd.

USD 2.55

-0.29%

CONCORDBIO.NS

Concord Biotech Limited

USD 20.87

-1.11%

002019.SZ

Yifan Pharmaceutical Co., Ltd.

USD 1.84

0.22%

9989.HK

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

USD 0.68

2.56%

002755.SZ

Beijing Aosaikang Pharmaceutical Co., Ltd.

USD 2.24

1.28%

NEULANDLAB.NS

Neuland Laboratories Limited

USD 142.84

0.20%

300294.SZ

China Resources Boya Bio-pharmaceutical Group Co., Ltd.

USD 3.57

-0.12%

4540.T

Tsumura & Co.

USD 23.21

1.27%

FAE.MC

Faes Farma, S.A.

USD 5.23

0.70%

LLY

Eli Lilly and Company

USD 770.64

1.04%

JNJ

Johnson & Johnson

USD 151.32

1.02%

ABBV

AbbVie Inc.

USD 183.76

-0.83%

RO.SW

Roche Holding AG

USD 339.66

0.85%

AZN.L

AstraZeneca PLC

USD 140.89

0.81%

MRK

Merck & Co., Inc.

USD 80.16

1.39%

AMGN

Amgen Inc.

USD 272.44

-5.84%

PFE

Pfizer Inc.

USD 24.03

0.25%

GILD

Gilead Sciences, Inc.

USD 106.19

-2.13%

SAN.PA

Sanofi

USD 96.16

0.29%

BMY

Bristol-Myers Squibb Company

USD 46.92

0.13%

MCK

McKesson Corporation

USD 721.83

0.13%

ELV

Elevance Health Inc.

USD 372.42

-0.56%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 51.71

0.69%

GSK.L

GSK plc

USD 18.97

0.58%

COR

Cencora, Inc.

USD 293.13

-0.18%

REGN

Regeneron Pharmaceuticals, Inc.

USD 511.92

0.43%

LONN.SW

Lonza Group AG

USD 688.40

0.56%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

0.15%

HLN.L

Haleon plc

USD 5.19

0.41%

SUNPHARMA.NS

Sun Pharmaceutical Industries Limited

USD 19.36

0.52%

4502.T

Takeda Pharmaceutical Company Limited

USD 29.87

1.96%

4568.T

Daiichi Sankyo Company, Limited

USD 23.15

2.56%

UCB.BR

UCB SA

USD 190.31

4.88%

SDZ.SW

Sandoz Group AG

USD 52.94

-0.71%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.73

2.31%

TEVA.TA

Teva Pharmaceutical Industries Limited

USD 17.10

-0.70%

StockViz Staff

June 24, 2025

Any question? Send us an email